nesiritide

美 　英

• 網(wǎng)絡(luò)奈西立肽；人腦利鈉肽；西利肽

例句

But metaanalyses raised the question of safety with nesiritide therapy, specifically an increased risk of renal dysfunction and mortality.

但是匯總分析發(fā)現(xiàn)奈西立肽有引起腎臟損害和死亡率增加的風(fēng)險。

Nesiritide is a synthetic form of brain natriuretic peptide using recombinant DNA technology.

奈西立肽是利用重組DNA技術(shù)得到的合成型人類腦利鈉肽。

The clinical study showed that nesiritide may improve the haemodynamics and the clinical symptoms of heart failure patients.

臨床研究表明奈西立肽可改善心力衰竭病人的血流動力學(xué)，改善心力衰竭病人的臨床癥狀。

Nesiritide is mainly indicated for the treatment of acute heart failure.

奈西立肽主要用于急性心力衰竭的治療。

In addition, nesiritide treatment was associated with reduced hospital stays and decreased mortality at 180 days.

而且，采用奈西立肽治療可縮減患者住院期以及降低半年內(nèi)死亡率。

Nesiritide: a safe and effective agent for acute decompensated heart failure

治療急性失代償性心力衰竭新藥奈西立肽